These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9330998)

  • 1. Do we need angiotensin II antagonists to treat hypertensive patients?
    Ménard J; Chatellier G; Azizi M
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S1-7. PubMed ID: 9330998
    [No Abstract]   [Full Text] [Related]  

  • 2. Candesartan cilexetil and enalapril are of equivalent efficacy in patients with mild to moderate hypertension.
    Zanchetti A; Omboni S; Di Biagio C
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S57-9. PubMed ID: 9331009
    [No Abstract]   [Full Text] [Related]  

  • 3. Antihypertensive effects of candesartan cilexetil, enalapril and placebo.
    Franke H
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S61-2. PubMed ID: 9331010
    [No Abstract]   [Full Text] [Related]  

  • 4. [Medical angiotensin II-receptor blockade in hypertension and heart failure].
    van Zwieten PA; Lie KI
    Ned Tijdschr Geneeskd; 1995 Jul; 139(30):1529-33. PubMed ID: 7675129
    [No Abstract]   [Full Text] [Related]  

  • 5. Losartan for hypertension.
    Med Lett Drugs Ther; 1995 Jun; 37(951):57-8. PubMed ID: 7783693
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin II antagonists DuP 753 and TCV 116.
    Brunner HR; Delacrétaz E; Nussberger J; Burnier M; Waeber B
    J Hypertens Suppl; 1994 Nov; 12(9):S29-34. PubMed ID: 7884581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Angiotensin-2 receptor blockade--new therapeutic approach to treatment of hypertension].
    Zimlichman R
    Harefuah; 1996 Jul; 131(1-2):43-5. PubMed ID: 8854479
    [No Abstract]   [Full Text] [Related]  

  • 8. The angiotensin II receptor antagonist losartan: a new advance in the treatment of hypertension.
    Lacourcière Y
    Can J Cardiol; 1995 Aug; 11 Suppl F():45F-48F. PubMed ID: 7664218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving prognosis in hypertension: exploring the benefits of angiotensin II type 1 receptor blockade.
    Ruilope L
    Blood Press Suppl; 2000; 1():31-5. PubMed ID: 11059634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Angiotensin-II-receptor antagonists for cardiac insufficiency].
    Kromer EP
    Internist (Berl); 2000 Sep; 41(9):917-24. PubMed ID: 11006881
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin antagonists.
    Brunner HR; Nussberger J; Waeber B
    Adv Nephrol Necker Hosp; 1993; 22():305-27. PubMed ID: 8427061
    [No Abstract]   [Full Text] [Related]  

  • 12. [Angiotensin II antagonists].
    Tikkanen I; Tikkanen T
    Duodecim; 1995; 111(18):1733-5. PubMed ID: 9340266
    [No Abstract]   [Full Text] [Related]  

  • 13. [Renin-angiotensin system blockade. What can be expected from angiotensin II antagonists?].
    Waeber B; Nussberger J; Brunner H
    Rev Prat; 1992 Oct; 42(16):2066-8. PubMed ID: 1485114
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin II receptor antagonists: new paradigms in the treatment of hypertension. Introduction.
    Meredith PA; Weber MA
    Blood Press Suppl; 2001; 1():4-5. PubMed ID: 11333012
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of the renin-angiotensin system in hypertension in the elderly.
    Nagano M; Higaki J; Mikami H; Ogihara T
    Blood Press Suppl; 1994; 5():130-3. PubMed ID: 7889195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
    Dahlöf B; Devereux R; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Julius S; Kjeldsen S; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H
    Am J Hypertens; 1997 Jul; 10(7 Pt 1):705-13. PubMed ID: 9234823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual angiotensin II blockade: a promise of enhanced renal protection?
    Thurston H
    J Hypertens; 2002 Apr; 20(4):607-9. PubMed ID: 11910292
    [No Abstract]   [Full Text] [Related]  

  • 18. [Angiotensin receptor antagonist for therapy of patients with hypertension].
    Rakugi H; Ogihara T
    Nihon Rinsho; 1997 Aug; 55(8):2075-80. PubMed ID: 9284426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Losartan in patients with renal insufficiency.
    de Zeeuw D; Gansevoort RT; de Jong PE
    Can J Cardiol; 1995 Aug; 11 Suppl F():41F-44F. PubMed ID: 7664217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Angiotensin II antagonist for heart insufficiency].
    Z Kardiol; 1997 Jun; 86(6 Suppl):1-8. PubMed ID: 9259867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.